Data / Drug companies / Shakti Lifescience Private Limited
Shakti Lifescience Private Limited: 15 products in the FDA NDC directory, labeler code 73774
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Shakti Lifescience Private Limited (labeler code 73774) lists 15 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 14, 2025.
The request: Watch Shakti Lifescience Private Limited (FDA labeler code 73774): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 73774
- Products in commercial distribution
- 15
- Packages
- 76
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 6
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 12, 2021
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 15 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Testosterone propionate | 73774-026 | Powder | Bulk ingredients | February 14, 2025 |
| Finasteride | 73774-025 | Powder | Bulk ingredients | February 14, 2025 |
| Dutsteride | 73774-024 | Powder | Bulk ingredients | February 3, 2025 |
| Budesonide | 73774-019 | Powder | Bulk ingredients | September 11, 2024 |
| Prednisolone sodium phosphate | 73774-018 | Powder | Bulk ingredients | December 27, 2023 |
| Testosterone cypionate | 73774-016 | Powder | Bulk ingredients | January 1, 2023 |
| Testosterone enanthate | 73774-015 | Powder | Bulk ingredients | January 1, 2023 |
| Testosterone | 73774-014 | Powder | Bulk ingredients | January 1, 2023 |
| Nandrolone decanoate | 73774-013 | Powder | Bulk ingredients | January 1, 2023 |
| Estradiol valerate | 73774-011 | Powder | Bulk ingredients | January 1, 2023 |
| Testosterone undecanoate | 73774-008 | Powder | Bulk ingredients | January 1, 2023 |
| Estradiol base | 73774-007 | Powder | Bulk ingredients | January 1, 2023 |
| Tibolone | 73774-006 | Powder | Bulk ingredients | January 1, 2023 |
| Estradiol valerate | 73774-004 | Powder | Bulk ingredients | March 10, 2022 |
| Estradiol cypionate | 73774-003 | Powder | Bulk ingredients | November 12, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.